JP2006500948A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500948A5
JP2006500948A5 JP2004541226A JP2004541226A JP2006500948A5 JP 2006500948 A5 JP2006500948 A5 JP 2006500948A5 JP 2004541226 A JP2004541226 A JP 2004541226A JP 2004541226 A JP2004541226 A JP 2004541226A JP 2006500948 A5 JP2006500948 A5 JP 2006500948A5
Authority
JP
Japan
Prior art keywords
pnc
compound
pancreatic cancer
treating
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004541226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500948A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2003/011817 external-priority patent/WO2004031412A2/en
Publication of JP2006500948A publication Critical patent/JP2006500948A/ja
Publication of JP2006500948A5 publication Critical patent/JP2006500948A5/ja
Pending legal-status Critical Current

Links

JP2004541226A 2002-09-30 2003-09-17 膵臓癌を診断する方法 Pending JP2006500948A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41487202P 2002-09-30 2002-09-30
US45088903P 2003-02-28 2003-02-28
PCT/JP2003/011817 WO2004031412A2 (en) 2002-09-30 2003-09-17 Method for diagnosing pancreatic cancer

Publications (2)

Publication Number Publication Date
JP2006500948A JP2006500948A (ja) 2006-01-12
JP2006500948A5 true JP2006500948A5 (enExample) 2006-11-02

Family

ID=32073343

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004541224A Expired - Fee Related JP4679149B2 (ja) 2002-09-30 2003-09-12 ヒト膵癌に関連する遺伝子およびポリペプチド
JP2004541226A Pending JP2006500948A (ja) 2002-09-30 2003-09-17 膵臓癌を診断する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004541224A Expired - Fee Related JP4679149B2 (ja) 2002-09-30 2003-09-12 ヒト膵癌に関連する遺伝子およびポリペプチド

Country Status (10)

Country Link
US (3) US7601826B2 (enExample)
EP (3) EP1556518B1 (enExample)
JP (2) JP4679149B2 (enExample)
CN (1) CN1703524B (enExample)
AT (2) ATE419391T1 (enExample)
AU (2) AU2003260966A1 (enExample)
CA (2) CA2500472A1 (enExample)
DE (2) DE60325628D1 (enExample)
ES (1) ES2320443T3 (enExample)
WO (2) WO2004031411A2 (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
US7217807B2 (en) 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
US7888497B2 (en) 2003-08-13 2011-02-15 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof
WO2005083086A2 (en) * 2004-02-27 2005-09-09 Oncotherapy Science, Inc. Epha4 as therapeutic target of prc and pdaca
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
JP5697297B2 (ja) 2004-05-14 2015-04-08 ロゼッタ ジノミクス リミテッド マイクロnasおよびその使用
US7687616B1 (en) 2004-05-14 2010-03-30 Rosetta Genomics Ltd Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof
CA3002661C (en) 2004-05-21 2022-03-15 The Board Of Trustees Of The University Of Arkansas Use of gene expression profiling to predict survival in cancer patient
US7795419B2 (en) 2004-05-26 2010-09-14 Rosetta Genomics Ltd. Viral and viral associated miRNAs and uses thereof
WO2006038904A2 (en) * 2004-08-06 2006-04-13 Applera Corporation Method and compositions for treating diseases targeting e-cadherin
DE102004042822A1 (de) * 2004-08-31 2006-03-16 Technische Universität Dresden Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
DE102004049897B4 (de) 2004-10-13 2007-11-22 Sirs-Lab Gmbh Verfahren zur Unterscheidung zwischen nichtinfektiösen und infektiösen Ursachen eines Multiorganversagens
WO2007013358A2 (en) * 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
JP2009508493A (ja) * 2005-09-19 2009-03-05 ベリデックス・エルエルシー すい臓がんを診断するための方法
WO2007091328A1 (ja) 2006-02-10 2007-08-16 Oncotherapy Science, Inc. 肺癌の治療方法
JP2009531273A (ja) 2006-02-28 2009-09-03 オンコセラピー・サイエンス株式会社 抗EphA4抗体のエフェクター機能を用いて細胞を障害する方法
US20090155799A1 (en) * 2006-03-02 2009-06-18 Yusuke Nakamura Methods for diagnosing pancreatic cancer using reg4 protein
CN1904072B (zh) * 2006-07-28 2012-07-18 浙江大学 一组筛选胰腺导管腺癌的基因组合及应用
JP2010501161A (ja) * 2006-08-18 2010-01-21 オンコセラピー・サイエンス株式会社 Reg4またはkiaa0101を過剰発現している癌の治療または予防
US7811778B2 (en) * 2006-09-06 2010-10-12 Vanderbilt University Methods of screening for gastrointestinal cancer
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
CA2696591C (en) * 2007-08-20 2016-10-11 Oncotherapy Science, Inc. Cdh3 peptide and medicinal agent comprising the same
CN108117584B (zh) 2007-08-20 2021-08-24 肿瘤疗法科学股份有限公司 Foxm1肽和包含foxm1肽的药剂
RU2011103199A (ru) 2008-06-30 2012-08-10 Онкотерапи Сайенс, Инк. (Jp) Антитела против cdh3, меченные радиоизотопной меткой, и их применение
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US20110262463A1 (en) * 2008-08-27 2011-10-27 ONCOTHERAPY SCIENCE ,inc. Syngr4 for target genes of cancer therapy and diagnosis
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100135991A1 (en) * 2008-11-17 2010-06-03 Chiu-Chen Huang Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Foxm1胜肽以及含此胜肽之疫苗
DE102010043541B4 (de) * 2009-12-16 2012-01-26 Technische Universität Dresden Verfahren und Mittel zur Vorhersage der Überlebensdauer beim Pankreaskarzinom durch Analyse von Biomarkern
JP5728718B2 (ja) 2009-12-28 2015-06-03 オンコセラピー・サイエンス株式会社 抗cdh3抗体およびその使用
US20130137748A1 (en) * 2010-02-03 2013-05-30 Oncotherapy Science, Inc. Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
CA2800023A1 (en) * 2010-06-01 2011-12-08 Metanomics Health Gmbh Means and methods for diagnosing pancreatic cancer in a subject
MX355020B (es) 2010-07-09 2018-04-02 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
JP5931874B2 (ja) * 2010-08-13 2016-06-08 ソマロジック・インコーポレーテッド 膵癌バイオマーカーおよびその使用
US20140031250A1 (en) 2010-10-07 2014-01-30 David Tsai Ting Biomarkers of Cancer
KR101297336B1 (ko) 2011-03-30 2013-08-14 인하대학교 산학협력단 점액성 낭성종양 진단 장치
KR101223598B1 (ko) 2011-04-06 2013-01-22 인하대학교 산학협력단 췌장 상피내 종양 진단 시스템
CN104011543B (zh) * 2011-10-24 2016-06-15 通用医疗公司 癌症的生物标记
EP3305916B1 (en) 2013-05-20 2019-06-26 BioVentures, LLC Gep5 model for multiple myeloma
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
BR112016020897A2 (pt) * 2014-03-11 2018-01-23 Council Queensland Inst Medical Res ?determinação da agressividade de câncer, prognóstico e capacidade de reação a tratamento?
WO2015171736A2 (en) * 2014-05-07 2015-11-12 University Of Utah Research Foundation Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
WO2015200697A1 (en) 2014-06-25 2015-12-30 The General Hospital Corporation Targeting human satellite ii (hsatii)
EP3198030B1 (en) 2014-09-26 2020-11-04 HI-STEM gGmbH Im Deutschen Krebsforschungszentrum DKFZ Novel methods for sub-typing and treating cancer
GB201501930D0 (en) * 2015-02-05 2015-03-25 Univ London Queen Mary Biomarkers for pancreatic cancer
JP2018136122A (ja) * 2015-05-29 2018-08-30 国立研究開発法人国立がん研究センター 膵がんを診断するための血漿バイオマーカーパネル
CN105017403B (zh) * 2015-07-09 2018-07-03 陈勇 胰腺癌相关多肽dap44单克隆抗体的制备及其应用
EP3360886B1 (en) 2015-10-08 2023-01-25 Oncotherapy Science, Inc. Foxm1-derived peptide, and vaccine including same
WO2019050036A1 (ja) * 2017-09-11 2019-03-14 国立大学法人北海道大学 癌治療薬
EP3508855A1 (en) * 2018-01-05 2019-07-10 Allianz Pharmascience Ltd Method for the selection of patients and kit
WO2019217706A1 (en) * 2018-05-11 2019-11-14 University Of Massachusetts Methods for improving leptin sensitivity for the treatment of obesity and diabetes
KR102328654B1 (ko) * 2019-04-17 2021-11-19 한국원자력의학원 암의 예방 또는 치료용 약학 조성물
KR102289278B1 (ko) * 2019-07-09 2021-08-13 주식회사 베르티스 췌장암 진단용 바이오마커 패널 및 그 용도
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN115074365B (zh) * 2022-06-28 2023-02-28 中国医学科学院北京协和医院 靶向GATM基因的sgRNA及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
AU7499198A (en) 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells
CA2315263A1 (en) * 1997-12-15 1999-06-24 Abbott Laboratories Reagents and methods useful for detecting diseases of the pancreas
US6262249B1 (en) * 1998-06-23 2001-07-17 Chiron Corporation Pancreatic cancer genes
US20020119158A1 (en) * 1998-12-17 2002-08-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6429302B1 (en) 1999-02-02 2002-08-06 Chiron Corporation Polynucleotides related to pancreatic disease
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU6181200A (en) 1999-07-29 2001-02-19 Helix Research Institute Stomach cancer-associated gene
EP1686134A3 (en) 1999-12-01 2006-08-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001055343A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1358349A2 (en) 2000-06-05 2003-11-05 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
US6974667B2 (en) 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
CA2469941A1 (en) * 2001-12-10 2003-07-03 Nuvelo, Inc. Novel nucleic acids and polypeptides
JP2006500946A (ja) 2002-09-30 2006-01-12 オンコセラピー・サイエンス株式会社 精巣精上皮腫の診断方法
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
US20050260639A1 (en) 2002-09-30 2005-11-24 Oncotherapy Science, Inc. Method for diagnosing pancreatic cancer
US20090155799A1 (en) * 2006-03-02 2009-06-18 Yusuke Nakamura Methods for diagnosing pancreatic cancer using reg4 protein

Similar Documents

Publication Publication Date Title
JP2006500948A5 (enExample)
JP2009502116A5 (enExample)
JP2006500949A5 (enExample)
JP2007506426A5 (enExample)
JP2009502115A5 (enExample)
JP2014509868A5 (enExample)
JP2010535014A5 (enExample)
JP2005537027A5 (enExample)
JP2008512984A5 (enExample)
JP2006503575A5 (enExample)
KR102657188B1 (ko) 분리된 세포로부터 프라이머를 이용하여 세포노화 바이오 마커를 검출하는 방법
JP2006500945A5 (enExample)
KR101334123B1 (ko) 소세포폐암 진단용 조성물 및 소세포폐암 진단키트
KR102803677B1 (ko) 전이성 유방암의 항암제 치료 반응성 및 예후 예측용 신규한 바이오마커 및 이의 용도
KR102028967B1 (ko) Rip1을 포함하는 폐암 전이 진단용 바이오 마커 및 이의 이용
JP2005509174A5 (enExample)